Towards the elimination of viral hepatitis in Thailand by the year 2030
Viral hepatitis is a global problem with mortality comparable to HIV, tuberculosis and malaria. The WHO aims to eliminate hepatitis B (HBV) and hepatitis C (HCV) by 2030. Improved socioeconomic status of developing countries such as Thailand has reduced the incidence and morbidity associated with he...
Saved in:
Main Authors: | Nawarat Posuwan (Author), Nasamon Wanlapakorn (Author), Palittiya Sintusek (Author), Rujipat Wasitthankasem (Author), Kittiyod Poovorawan (Author), Sompong Vongpunsawad (Author), Yong Poovorawan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand
by: Teeraporn Chinchai, et al.
Published: (2019) -
Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand
by: Thanunrat Thongmee, et al.
Published: (2024) -
Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines
by: Nasamon Wanlapakorn, et al.
Published: (2024) -
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
by: Stephanie Popping, et al.
Published: (2019) -
Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
by: Nungruthai Suntronwong, et al.
Published: (2023)